Simultaneous MR arteriography and venography with blood pool contrast agent detects deep venous thrombosis in suspected arterial disease

American Journal of Roentgenology

Volumn 198, Issue 5, 2012, Pages 1188-1195

  Hadizadeh, Dariusch R ^a   Kukuk, Guido M ^a   Fahlenkamp, Ute L ^a   Pressacco, Josephine ^b   Schäfer, Christian ^a   Rabe, Eberhard ^a   Koscielny, Arne ^a   Verrel, Frauke ^a   Schild, Hans H ^a   Willinek, Winfried A ^a  

^a UNIVERSITY OF BONN   (Germany)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Arterial stenosis; Blood pool contrast agent; MR angiography; MR venography; Venous thrombosis

Indexed keywords

CONTRAST MEDIUM; GADOFOSVESET;

ACUTE DISEASE; ADULT; AGED; ARTERIOGRAPHY; ARTERY OCCLUSION; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECHOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; INCIDENTAL FINDING; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE ARTERIOGRAPHY; MAGNETIC RESONANCE VENOGRAPHY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHLEBOGRAPHY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INCIDENTAL FINDINGS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PERIPHERAL VASCULAR DISEASES; PREVALENCE; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VENOUS THROMBOSIS;

EID: 84860341477     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7306     Document Type: Article

References (35)

1. Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF. Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR 2000; 174:1127-1135 (Pubitemid 30180017)
2. Ruehm SG, Goyen M, Barkhausen J, et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 2001; 357:1086-1091 (Pubitemid 32322540)
3. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998; 207:529-538 (Pubitemid 28259074)
4. Goyen M, Edelman M, Perreault P, et al. MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 2005; 236:825-833 (Pubitemid 41170843)
5. Nikolaou K, Kramer H, Grosse C, et al. Highspatial- resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology 2006; 241:861-872 (Pubitemid 46190554)
6. Kos S, Reisinger C, Aschwanden M, Bongartz GM, Jacob AL, Bilecen D. Pedal angiography in peripheral arterial occlusive disease: first-pass IV contrast-enhanced MR angiography with blood pool contrast medium versus intraarterial digital subtraction angiography. AJR 2009; 192:775-784
7. van Langevelde K, Tan M, Sramek A, Huisman MV, de Roos A. Magnetic resonance imaging and computed tomography developments in imaging of venous thromboembolism. J Magn Reson Imaging 2010; 32:1302-1312
8. Parmelee DJ, Walovitch RC, Ouellet HS, Lauffer RB. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997; 32:741-747 (Pubitemid 28053505)
9. Grist TM, Korosec FR, Peters DC, et al. Steadystate and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998; 207:539-544 (Pubitemid 28259075)
10. Hadizadeh DR, Gieseke J, Lohmaier SH, et al. Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA. Radiology 2008; 249:701-711
11. Hartmann M, Wiethoff AJ, Hentrich HR, Rohrer M. Initial imaging recommendations for Vasovist angiography. Eur Radiol 2006; 16(suppl 2):B15-B23
12. Hamper UM, DeJong MR, Scoutt LM. Ultrasound evaluation of the lower extremity veins. Radiol Clin North Am 2007; 45:525-547 [ix] (Pubitemid 46963346)
13. Wang MS, Haynor DR, Wilson GJ, Maki JH. Intravascular hematocrit layering in equilibrium phase contrast-enhanced MR angiography of the peripheral vasculature. J Magn Reson Imaging 2006; 24:1393-1400 (Pubitemid 44871887)
14. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest 2008; 133(suppl 6):454S-545S (Pubitemid 351892971)
15. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117:93-102 (Pubitemid 350301144)
16. Eliasson A, Bergqvist D, Bjorck M, Acosta S, Sternby NH, Ogren M. Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23,796 consecutive autopsies. J Thromb Haemost 2006; 4:1897-1902 (Pubitemid 44226765)
17. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348:1435-1441 (Pubitemid 36407172)
18. Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007; 370:1773-1779 (Pubitemid 350137491)
19. Agnelli G, Becattini C. Venous thromboembolism and atherosclerosis: common denominators or different diseases? J Thromb Haemost 2006; 4:1886-1890 (Pubitemid 44226763)
20. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158:585-593 (Pubitemid 28144815)
21. Linkins LA, Stretton R, Probyn L, Kearon C. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. Thromb Res 2006; 117:241-247 (Pubitemid 41832294)
22. AbuRahma AF, Powell M, Robinson PA. Prospective study of safety of lower extremity phlebography with nonionic contrast medium. Am J Surg 1996; 171:255-260
23. Lensing AW, Prandoni P, Buller HR, Casara D, Cogo A, ten Cate JW. Lower extremity venography with iohexol: results and complications. Radiology 1990; 177:503-505 (Pubitemid 20374874)
24. Orbell JH, Smith A, Burnand KG, Waltham M. Imaging of deep vein thrombosis. Br J Surg 2008; 95:137-146
25. Wang MS, Haynor DR, Wilson GJ, Leiner T, Maki JH. Maximizing contrast-to-noise ratio in ultra-high resolution peripheral MR angiography using a blood pool agent and parallel imaging. J Magn Reson Imaging 2007; 26:580-588 (Pubitemid 350194579)
26. Aschauer M, Deutschmann HA, Stollberger R, et al. Value of a blood pool contrast agent in MR venography of the lower extremities and pelvis: preliminary results in 12 patients. Magn Reson Med 2003; 50:993-1002 (Pubitemid 37356579)
27. Enden T, Storas TH, Negard A, et al. Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA). J Magn Reson Imaging 2010; 31:416-424
28. Hoffmann U, Loewe C, Bernhard C, et al. MRA of the lower extremities in patients with pulmonary embolism using a blood pool contrast agent: initial experience. J Magn Reson Imaging 2002; 15:429-437 (Pubitemid 34252405)
29. Du YP, Jin Z. Simultaneous acquisition of MR angiography and venography (MRAV). Magn Reson Med 2008; 59:954-958 (Pubitemid 351590506)
30. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy: the emerging theme of delayed recurrence. Arch Intern Med 1997; 157:2317-2321 (Pubitemid 27479330)
31. Perreault P, Edelman MA, Baum RA, et al. MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial. Radiology 2003; 229:811-820 (Pubitemid 37467588)
32. Rapp JH, Wolff SD, Quinn SF, et al. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset - enhanced MR angiography-multicenter comparative phase III study. Radiology 2005; 236:71-78 (Pubitemid 40853296)
33. Bongartz G. Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? MAGMA 2007; 20:57-62 (Pubitemid 46684541)
34. Goodacre S, Sampson F, Stevenson M, et al. Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis. Health Technol Assess 2006; 10:1-168
35. Visser K, de Vries SO, Kitslaar PJ, van Engelshoven JM, Hunink MG. Cost-effectiveness of diagnostic imaging work-up and treatment for patients with intermittent claudication in The Netherlands. Eur J Vasc Endovasc Surg 2003; 25:213-223 (Pubitemid 36527614)